Esther Rajavelu

Stock Analyst at UBS

(1.20)
# 3,586
Out of 4,893 analysts
26
Total ratings
46.67%
Success rate
n/a
Average return

Stocks Rated by Esther Rajavelu

Alnylam Pharmaceuticals
May 2, 2025
Maintains: Buy
Price Target: $331$349
Current: $320.87
Upside: +8.77%
Applied Therapeutics
Dec 2, 2024
Downgrades: Neutral
Price Target: $13$2
Current: $0.40
Upside: +406.33%
Denali Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $70$32
Current: $15.00
Upside: +113.33%
Ultragenyx Pharmaceutical
Aug 19, 2021
Initiates: Sell
Price Target: $73
Current: $41.44
Upside: +76.16%
Biohaven
Aug 10, 2021
Downgrades: Neutral
Price Target: $108$109
Current: $14.48
Upside: +652.76%
Stoke Therapeutics
May 18, 2021
Initiates: Neutral
Price Target: $35
Current: $12.02
Upside: +191.18%
Ionis Pharmaceuticals
May 7, 2021
Upgrades: Neutral
Price Target: $33$38
Current: $42.83
Upside: -12.44%
Jazz Pharmaceuticals
Mar 1, 2021
Maintains: Buy
Price Target: $174$228
Current: $111.60
Upside: +104.30%
Arrowhead Pharmaceuticals
Dec 13, 2019
Initiates: Perform
Price Target: n/a
Current: $18.88
Upside: -
Innoviva
Nov 20, 2017
Initiates: Hold
Price Target: $13
Current: $19.17
Upside: -32.19%
Initiates: Buy
Price Target: $10
Current: $1.22
Upside: +719.67%